[HTML] from plos.orgUL Abbas, G Hood, AW Wetzel… - PloS one, 2011 - dx.plos.org ... Analyses suggest that the prevalence of HIV drug resistance is influenced most by the extent and duration of inadvertent PrEPuse in individuals already infected with HIV. ... Both the rate and duration of inadvertent PrEPuse are key factors. ... Related articles - Cached - All 3 versions
[PDF] from cdc.govCDCF SHEET - 2011 - cdc.gov ... Initial and regular HIV testing is critical for anyone considering using PrEP. All individuals considering PrEP must also be evaluated for other health conditions that may impact PrEPuse. ... Developing Formal US Public Health Service Guidelines on PrEPUse... Related articles - View as HTML - All 5 versions
[PDF] from rectalmicrobicides.orgJT Galea, JJ Kinsler, X Salazar… - … journal of STD & …, 2011 - ijsa.rsmjournals.com ... 0.001). Focus group data supported these findings, and also revealed that potential sexual risk disinhibition, stigma and discrimination associated with PrEPuse, and mistrust of health-care professionals were also concerns. ... Cited by 1 - Related articles - All 7 versions
G Mansergh, B Koblin, GN Colfax… - Sexually Transmitted …, 2011 - sti.bmj.com ... In multivariate analysis, no variables were associated (p>0.05) with sharing ART for PrEPuse; 'less education' was linked to sharing for PEP use, compared with men with some post-high school education (OR=2.7, CI=1.0 to 7.2 (p=0.05)) or a college degree or more education ...
GM Myers… - AIDS Patient Care and STDs, 2011 - liebertonline.com ... 33 One other concern about the use of TDF and FTC for PrEP is that they each have activity against hepatitis B, so that intermittent PrEPuse or erratic adherence could result in the development of drug resistance in hepatitis B-infected individuals, and potential flares of virologic ... Cited by 5 - Related articles - All 2 versions